LEUVEN, Belgium and LUND, Sweden, December 16, 2011 - ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce today that they have completed the enrolment of a 632-patient Phase IIb trial with their novel long-acting anticoagulant TB-402 (factor VIII inhibitor) for the prophylaxis of venous thromboembolism (VTE) after total hip surgery.

LONDON, PARIS, MUNICH, and BRUSSELS, December 15, 2011 - Egencia™, an Expedia, Inc.

LONDON, December 15, 2011 - We are pleased to announce Key Travel N.V.

BRUSSELS, December 15, 2011 - Russia's accession to the World Trade Organization (WTO) will spur an increase in mutual Russian-European investment, and European companies should look East to the Russian market for new sources of growth.

BRUSSELS and HERAKLION, Greece, December 16, 2011 - The EU’s "cyber security" Agency ENISA has published astudyinto legal and regulatory aspects of information sharing and cross-border collaboration of national/governmental CERTs (Computer Emergency Response Teams)in Europe.
Older News
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
Copyright© 2011 The Gaea Times